Does Frailty Help Predict Postoperative Outcomes in Cardiac Surgery?
Launched by KING'S COLLEGE HOSPITAL NHS TRUST · Apr 19, 2016
Trial Information
Current as of July 21, 2025
Unknown status
Keywords
ClinConnect Summary
Increasingly, the group of patients undergoing cardiac surgery are older. Patients that are more elderly and frail are known to have an increase risk of injury to major organs following surgery including the heart, kidneys, and brain, all of which are associated with worse survival or diminished quality of life. It is becoming more important to be able to predict how well patients will fair in cardiac surgery, including predicting risk of complications (such as stroke or heart attacks) as well as long-term survival and quality of life. Currently, scores such as EUROscore can be used with go...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 18 years or over
- • Due to undergo elective cardiac surgery: coronary artery bypass graft (CABG); valve replacement/repair; or transcatheter aortic valve implantation (TAVI) surgery
- • Able to give informed consent
- • Fluency in English
- Exclusion Criteria:
- • Emergency cardiac surgery and non-cardiac surgery
- • Inadequate knowledge of English that will prevent patients from completing the consent or undertaking study assessments
- • Severe visual, auditory, or motor handicap
- • Concurrent diseases of the central nervous system,
- • Patients at the extremes of frailty, in whom it would be unethical to perform a full assessment.
About King's College Hospital Nhs Trust
King's College Hospital NHS Trust is a leading healthcare institution in the United Kingdom, renowned for its commitment to providing high-quality patient care and advancing medical research. With a strong emphasis on clinical excellence, the Trust supports a wide range of clinical trials across various specialties, leveraging its state-of-the-art facilities and a multidisciplinary team of healthcare professionals. By fostering innovation and collaboration, King's College Hospital NHS Trust aims to enhance treatment options and improve outcomes for patients, while contributing to the global body of medical knowledge through rigorous scientific investigation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Joshua Lucas de Carvalho
Principal Investigator
King's College London
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials